Amber Therapeutics
Latest round
- Series A
Last raised
- Jun 2024
Total raised
- $101M
Investors
- 7
About Amber Therapeutics
Based in London, UK, and founded in 2021, Amber Therapeutics Limited provides next-generation, intelligent bioelectrical therapies. The company was founded by Aidan Crawley (CEO) and Tim Dension. The company develops therapies such as bioelectrical therapies in order to improve clinical outcomes for patients with functional impairments of the peripheral nervous system. The firm therapy includes Amber-UI a fully implantable closed-loop bioelectrical therapy that is now in clinical development with the goal of treating urge and mixed urine incontinence (UI).
Who invested in Amber Therapeutics
7 investors across 2 rounds
See all investors in Amber Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amber Therapeutics
Who invested in Amber Therapeutics?
Amber Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amber Therapeutics raised?
Amber Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Amber Therapeutics last raise money?
Amber Therapeutics's most recent round on record is a Series A, in Jun 2024.
What does Amber Therapeutics do?
Based in London, UK, and founded in 2021, Amber Therapeutics Limited provides next-generation, intelligent bioelectrical therapies.
Where is Amber Therapeutics headquartered?
Amber Therapeutics is headquartered in London, UK.
Which VCs invest in companies like Amber Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Amber Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Amber Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.